[vc_row el_class=”banner otherPage” el_id=”contact”][vc_column][vc_widget_sidebar sidebar_id=”header-banner” el_class=”contact_page_banner”][/vc_column][/vc_row][vc_row el_class=”innerPageContent”][vc_column el_class=”homeTab common otherPage”][vc_widget_sidebar sidebar_id=”breadcrumbs” el_class=”contact-breadcrumbs”][/vc_column][/vc_row][vc_row el_class=”serviceFormDiv outerWrapper contactpageContactform”][vc_column][vc_row_inner el_class=”wrapper”][vc_column_inner el_class=”sym”][vc_column_text]
Please join us for a Symposium on Genomics based biomarker discovery in cancer
At Foundry and Lux, 151 Oyster Point Blvd, South San Francisco, CA on November 19, 2018, 6:00 pm to 9:00 pm PST
Corporate co-sponsors
Dr. David Christiani Elkan Blout Professor of Environmental Genetics, Harvard T.H. Chan School of Public Health Topic: A Multi-Omics Approach for the study of Lung Adenocarcinoma |
Dr. Prithwish Pal Sr. Market Development Manager, Oncology, Illumina, Inc. Topic: Genomic Biomarkers for Immuno-therapy: Tumor Mutational Burden (TMB), and beyond |
Dr. Papia Chakraborty Sr. Scientist and Head of Immuno-oncology, MedGenome Inc. Topic: TCR-based immunogenicity prediction and screening solutions for immunotherapy research |
[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner disable_element=”yes” el_class=”serviceForm wrapper contact-page-contact-form”][vc_column_inner el_class=”leftAlign bgAlign”]